A Scoping Review of Pharmacotherapy, Complementary, and Alternative Medicine (CAM), and Surgical Therapies for Androgenic Alopecia

Purpose of Review Androgenic alopecia ( AGA) is the most common form of non-scarring alopecia, affecting millions of men and women in the United States (U.S.). This review highlights alternative and complementary treatment options for AGA. Recent Findings The treatment regimens for AGA have increase...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current dermatology reports 2021-06, Vol.10 (2), p.48-54
Hauptverfasser: Presley, Colby L., Kolodziejczyk, Tesia C., Pulsipher, Kayd J., Maghfour, Jalal, Militello, Michelle, Rietcheck, Hope R., Fonseca, Allene, Olayinka, Temitope J., Rundle, Chandler W., Waller, Jacquelyn D., Dellavalle, Robert P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose of Review Androgenic alopecia ( AGA) is the most common form of non-scarring alopecia, affecting millions of men and women in the United States (U.S.). This review highlights alternative and complementary treatment options for AGA. Recent Findings The treatment regimens for AGA have increased in pharmacotherapeutics, surgical, and complementary (CAM) categories. Each of the different treatment approaches can now be utilized by dermatologists to combat patient hair loss. Summary The U.S. Food and Drug Administration (FDA) has approved only two agents to treat AGA: prescription-only, oral finasteride and over-the-counter (OTC), topical minoxidil. Increased availability of therapies claiming hair regrowth properties, coupled with limited pharmacotherapeutic options for AGA, lead patients to seek alternative treatments. Increased awareness of the current evidence supporting complementary and alternative therapies among dermatologists will facilitate appropriate and timely education of AGA patients.
ISSN:2162-4933
2162-4933
DOI:10.1007/s13671-021-00331-8